ASX:UBI Universal Biosensors (UBI) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free UBI Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume10,006 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield8.55%Price TargetN/A Stock AnalysisStock Analysis Get Universal Biosensors alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Universal Biosensors Stock (ASX:UBI)Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices used in healthcare (point-of-care), wine, food, and agriculture industries in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, and fructose. It also offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans. Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… UBI Stock News HeadlinesFebruary 10, 2024 | reuters.comFact Check: No evidence World Economic Forum is microchipping Britons in return for UBIJanuary 22, 2024 | finance.yahoo.comIs Universal Biosensors (ASX:UBI) In A Good Position To Invest In Growth?April 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 7, 2023 | finance.yahoo.comMultiple insiders bought Universal Biosensors, Inc. (ASX:UBI) stock earlier this year, a positive sign for shareholdersFebruary 25, 2023 | finance.yahoo.comUniversal Biosensors Full Year 2022 Earnings: Misses ExpectationsFebruary 22, 2023 | finance.yahoo.comUBI Global Names Embarc Collective Among the World’s Top Challengers in Annual Rankings of Business Incubators and AcceleratorsFebruary 21, 2023 | newsweek.comUBI Business SchoolFebruary 20, 2023 | marketwatch.comBiosensors Market Size, Share and Forecast 2028 with Top Countries DataApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.February 20, 2023 | marketwatch.comBiosensors Market 2023: See a Rapid Rise in Revenues of 24052.35 Million by 2028 With 10.82% CAGR | 116 Pages ReportJanuary 19, 2023 | finance.yahoo.comWill Universal Biosensors (ASX:UBI) Spend Its Cash Wisely?November 25, 2022 | forbes.comUniversal Basic Income (UBI)November 17, 2022 | msn.comASX Health Stocks: UBI graces front cover of world-leading Journal; Neurotech preps Phase II/III trialOctober 7, 2022 | morningstar.comUniversal Biosensors Inc Shs Chess Depository Interests US Prohibited reprOctober 4, 2022 | finance.yahoo.comQuite a few insiders invested in Universal Biosensors, Inc. (ASX:UBI) last year which is positive news for shareholdersSeptember 28, 2022 | marketwatch.comBiosensors Market 2022 : Detailed Analysis of Industry, Potential Growth, Attractive Valuation and Growth Forecast Up to 2027September 7, 2022 | finance.yahoo.comUniversal Biosensors, Inc.'s (ASX:UBI) Profit OutlookSeptember 7, 2022 | finance.yahoo.comTencent Deal Cools Investors’ Hopes of Ubisoft TakeoverSeptember 7, 2022 | finance.yahoo.comTencent Looks Abroad to Level UpAugust 20, 2022 | reuters.comUniversal Biosensors IncAugust 11, 2022 | finance.yahoo.comUniversal Biosensors (ASX:UBI) Is In A Good Position To Deliver On Growth PlansMay 17, 2022 | finance.yahoo.comThose who invested in Universal Biosensors (ASX:UBI) three years ago are up 140%March 31, 2022 | finance.yahoo.comUniversal Biosensors, Inc. (ASX:UBI) Is Expected To Breakeven In The Near FutureFebruary 4, 2022 | marketwatch.comBiosensor Market Research Report (2021 to 2026) – by Technology, Type of Display, Service, Deployment and RegionJanuary 31, 2022 | finance.yahoo.comWhat Type Of Shareholders Make Up Universal Biosensors, Inc.'s (ASX:UBI) Share Registry?December 24, 2021 | msn.comUniversal Biosensors (ASX:UBI) share price up on “global first” 30-second COVID-19 testNovember 30, 2021 | finance.yahoo.comWe Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business GrowthSee More Headlines Receive UBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Universal Biosensors and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2019Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:UBI CUSIPN/A CIKN/A Webwww.universalbiosensors.com Phone+61-3-92139000FaxN/AEmployees80Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,740,000.00 Net Margins-101.64% Pretax MarginN/A Return on Equity-29.57% Return on Assets-27.39% Debt Debt-to-Equity Ratio25.49 Current Ratio3.70 Quick Ratio2.13 Sales & Book Value Annual Sales$6.63 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.26 Book ValueA$0.09 per share Price / BookN/AMiscellaneous Outstanding Shares212,370,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.92 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. John Stewart Sharman B Ec (Age 58)BECON, C.A., CA, M.App.Fin, Chief Executive Officer Comp: $532.42kMr. Salesh Balak B.A. (Age 55)BA, C.A., CA, CFO & Company Secretary Comp: $303.9kMr. Nicholas BliesnerHead of OperationsMr. Steven BurgessHead of Sales & MarketingMr. Luke Cossins B.Sc.M.B.A., Head of Research & DevelopmentMs. Ann Chew B.Com.CPA, CIA, Head of People Strategy & CultureMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersCraig ColemanSold 1,000,000 sharesTotal: $200,000.00 ($0.20/share)Graham McLeanBought 75,000 shares on 12/11/2023Total: $14,925.00 ($0.20/share)Craig ColemanBought 100,000 shares on 9/11/2023Total: $22,000.00 ($0.22/share)David HoeyBought 95,983 shares on 6/30/2023Total: $16,125.14 ($0.17/share) UBI Stock Analysis - Frequently Asked Questions How were Universal Biosensors' earnings last quarter? Universal Biosensors, Inc. (ASX:UBI) issued its quarterly earnings data on Tuesday, April, 30th. The company reported ($0.01) earnings per share for the quarter. Universal Biosensors had a negative trailing twelve-month return on equity of 29.57% and a negative net margin of 101.64%. This page (ASX:UBI) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universal Biosensors, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
